<?xml version="1.0" encoding="UTF-8"?>
<p id="p0095">Early reports from China indicated a high incidence of other neurological complications in COVID-19. Encephalopathy, presenting as headache with delirium and coma, associated with cerebral oedema and non-inflammatory CSF, was reported in about 20% of ICU patients in one series.
 <xref rid="bib38" ref-type="bibr">
  <sup>38</sup>
 </xref> The aetiology is likely a combination of hypoxaemia and metabolic derangement. An inflammatory COVID encephalitis has also been reported presenting as headache, fever, vomiting, and reduced level of consciousness. Ischaemic stroke was reported in around 5% of severely ill patients in a Wuhan series
 <xref rid="bib35" ref-type="bibr">
  <sup>35</sup>
 </xref> and in 2.5% in a report from Italy.
 <xref rid="bib39" ref-type="bibr">
  <sup>39</sup>
 </xref> Stroke is thought to be related to cytokine release and is associated with thrombocytosis. Finally, there are an increasing number of case reports of other associated neurological presentations, including Guillain–Barré syndrome,
 <xref rid="bib40" ref-type="bibr">
  <sup>40</sup>
 </xref>
 <sup>,</sup>
 <xref rid="bib41" ref-type="bibr">
  <sup>41</sup>
 </xref> Miller Fisher syndrome, meningitis, and subarachnoid haemorrhage.
</p>
